60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Stock Short Interest Falls 42.9%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 1,102 shares, a decline of 42.9% from the September 15th total of 1,931 shares. Based on an average daily trading volume, of 1,592 shares, the short-interest ratio is presently 0.7 days.

60 Degrees Pharmaceuticals Price Performance

Shares of NASDAQ:SXTPW traded down $0.00 during midday trading on Friday, reaching $0.02. The company had a trading volume of 5,001 shares, compared to its average volume of 9,363. 60 Degrees Pharmaceuticals has a 52-week low of $0.02 and a 52-week high of $0.15. The company’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.04.

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc is a specialty pharmaceutical company focused on developing and commercializing medicines for infectious diseases. The company’s work has centered primarily on diseases that affect travelers, military personnel, and people living in or visiting tropical and other high-risk regions.

Its lead product is Arakoda (tafenoquine), an FDA-approved prescription medicine for the prevention of malaria in adults. Tafenoquine is an antimalarial compound designed for longer-lasting protection than many traditional prophylactic options.